Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis

SUMMARY: BACKGROUND AND OBJECTIVES: Fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality in patients with ESRD. Before FGF23 testing can be integrated into clinical practice of ESRD, further understanding of its determinants is needed. DESIGN, SETTING, PARTICIPANTS, &...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Isakova, Tamara, Xie, Huiliang, Barchi-Chung, Allison, Vargas, Gabriela, Sowden, Nicole, Houston, Jessica, Wahl, Patricia, Lundquist, Andrew, Epstein, Michael, Smith, Kelsey, Contreras, Gabriel, Ortega, Luis, Lenz, Oliver, Briones, Patricia, Egbert, Phyllis, Ikizler, T. Alp, Jueppner, Harald, Wolf, Myles
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2011
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206004/
https://ncbi.nlm.nih.gov/pubmed/21903990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04290511
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars